Decadron Related Clinical Trials
Dexamethasone for Paediatric Adeno-Tonsillectomy - A Dose-Finding Study [Terminated]
XERECEPT® (hCRF) for Patients Requiring Dexamethasone to Treat Edema Associated With Brain Tumors [Completed]
Dexamethasone Study: Impact on Quality of Life of Continuing Dexamethasone Following Emetogenic Chemotherapy [Recruiting]
Aprepitant With Dexamethasone Versus Ondansetron With Dexamethasone for PONV Prophylaxis in Patients Having Craniotomy [Recruiting]
Vincristine, DOXIL® (Doxorubicin HCl Liposome Injection) and Dexamethasone vs. Vincristine, Doxorubicin, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma [Completed]
Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction [Recruiting]
Prevention of Cisplatin-Induced Hearing Loss by Intratympanic Dexamethasone Treatment [Recruiting]
Pegylated Liposomal Doxorubicin, Low Freq Dexamethasone & Revlimid (Dd-R) in Newly Diagnosed MM [Recruiting]
Dasatinib in Combination With Revlimid (and Dexamethasone) [Recruiting]
Effects of Steroid Tapering on Functional Capacity and Neurocognition [Not yet recruiting]
Dexamethasone Intravitreal Implant After Vitrectomy For Epiretinal Membrane [Not yet recruiting]
Pomalidomide, Bortezomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma [Recruiting]
Study of Bortezomib and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma [Not yet recruiting]
Ropivacaine Block Alone or With Perineural or Systemic Dexamethasone for Pain in Shoulder Surgery [Recruiting]
Combination Therapy Using Lenalidomide (Revlimid)- Low Dose Dexamethasone and Rituximab for Treatment of Rituximab-Resistant, Non-Aggressive B-Cell Lymphomas [Recruiting]
The Efficacy of Dexamethasone Versus Dexamethasone Combined With Rituximab in Patients With Newly Diagnosed Idiopathic Thrombocytopenic Purpura (ITP) [Recruiting]
Bortezomib/Dexamethasone (BD), Followed By Autologous Stem Cell Transplantation and Maintenance Bortezomib/Dexamethasone For the Initial Treatment of Monoclonal Immunoglobulin Deposition Disease (MIDD) Associated With Multiple Myeloma and AL Amyloidosis [Recruiting]
Randomized Study for Effectiveness and Safety Evaluation of Dexamethasone 0.5 mg + Fumarate Clemastine 1 mg Compared to Dexamethasone 0.5 mg in Patients With Allergic Dermatitis [Not yet recruiting]
Combination Therapy of Lenalidomide/Bortezomib/Dexamethasone and Panobinostat in Transplant Eligible New Diagnosed Multiple Myeloma (MM) Patients [Not yet recruiting]
Study to Compare Efficacy and Safety of Pomalidomide in Combination With Low-dose Dexamethasone Versus High-dose Dexamethasone in Subjects With Refractory or Relapsed and Refractory Multiple Myeloma [Recruiting]
Dexamethasone in the Treatment of Bronchiolitis in Patients With Either Eczema and or Family History of Asthma [Recruiting]
Low Dose Versus High Dose Dexamethasone for Symptom Control in Children Undergoing Cranial or Craniospinal Radiation [Recruiting]
Study of Decadron, Biaxin, and Pomalidomide in Relapsed/Refractory Myeloma [Recruiting]
Comparison of Initial Ozurdex (Dexamethasone Implant) to Avastin (Bevacizumab) for Treatment of Macular Edema Caused by Central Retinal Vein Occlusion (CRVO) [Recruiting]
Bendamustine Hydrochloride, Lenalidomide, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma [Recruiting]
A Study of MLN9708 Administered in Combination With Lenalidomide and Low-Dose Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma [Recruiting]
Dexamethasone or Dexamethasone in Combination With Thalidomide as Salvage Therapy [Completed]
Safety and Efficacy of Aprepitant, Ramosetron, and Dexamethasone for Chemotherapy-Induced Nausea and Vomiting in Patients With Ovarian Cancer Treated With Taxane/Carboplatin [Not yet recruiting]
Randomized Phase II Trial of Doxil With or Without Dexamethasone for Metastatic Hormone Refractory Prostate Cancer [Terminated]
Aplidin - Dexamethasone in Relapsed/Refractory Myeloma [Recruiting]
Phase II Study of Dexamethasone, Thalidomide and Lenalidomide for Subjects With Relapsed or Refractory Multiple Myeloma [Active, not recruiting]
Efficacy of Dexamethasone for Prevent Vomiting in Leukemic Children Who Receive Intrathecal Chemotherapy [Recruiting]
Comparison of High Dose and Low Dose Dexamethasone in Preventing Post-Extubation Airway Obstruction in Adults [Recruiting]
Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65 [Not yet recruiting]
Thalidomide + Dexamethasone vs. DOXIL (Doxorubicin HCl Liposome Injection) + Thalidomide + Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma [Active, not recruiting]
Dexamethasone for Symptom Burden in Advanced Cancer Patients [Recruiting]
Lenalidomide, Thalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma [Recruiting]
Lenalidomide, Dexamethasone and Cyclophosphamide in Amyloidosis (AL) [Recruiting]
Study of the Combination of Bortezomib, Dexamethasone, and Rituximab in Patients With Waldenstroms Macroglobulinemia [Active, not recruiting]
The Effectiveness of Oral Dexamethasone for Acute Bronchiolitis [Completed]
XERECEPT® (hCRF) for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain Edema [Withdrawn]
Fludarabine, Mitoxantrone, and Dexamethasone (FND) Plus Rituximab for Lymphoma Patients [Active, not recruiting]
A Study to Assess the Safety & Interaction Between GW679769, Dexamethasone, & Ondansetron When Taken by Healthy Adults [Completed]
Phase II Study of Biaxin, Revlimid, and Dexamethasone for Untreated Multiple Myeloma [Active, not recruiting]
Phase III Randomized Trial of Thalidomide/Dexamethasone vs VAD.
Continuous Infusion of Dexamethasone Plus Tramadol Adjunct to Morphine PCA After Abdominal Hysterectomy [Completed]
Maintenance Therapy After Thalidomide-Dexamethasone(ThaDD) for Multiple Myeloma(MM) [Completed]
Dexamethasone With or Without Thalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma [Completed]
Dexamethasone, Aspirin, and Diethylstilbestrol in Treating Patients With Locally Advanced or Metastatic Prostate Cancer [Completed]
Liposomal Vincristine Plus Dexamethasone in Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia [Completed]
Reduced Dexamethasone Pre-Medication Dose in Elderly Patients Receiving Weekly Docetaxel
Efficacy of Intravenous (IV) Palo With IV Dexamethasone Versus IV Palo for Prevention of Immediate and Delayed Post-Operative Nausea/Vomiting [Recruiting]
CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple Myeloma
Randomized Phase 2 Trial of Pre-Chemotherapy Leukine Vs. Leukine-Dexamethasone in Combination With Gemzar & 5-FU in Patients With Metastatic Renal Cell Carcinoma [Withdrawn]
A Study of CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple Myeloma
Phase 1/2 Study of VELCADE® in Combination With Other Drugs to Treat Previously Untreated Multiple Myeloma Patients [Recruiting]
Methotrexate, Vincristine, Pegylated L-Asparaginase and Dexamethasone (MOAD) in Acute Lymphoblastic Leukemia (ALL) Salvage [Recruiting]
GCS-100 in Combination With Etoposide and Dexamethasone in Relapsed or Refractory Diffuse Large B-Cell Lymphoma [Recruiting]
Bortezomib, Doxorubicin Hydrochloride Liposome, and Dexamethasone Followed by Thalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Multiple Myeloma [Recruiting]
The Effects of Dexamethasone on the Duration of Sciatic Nerve Blocks [Recruiting]
GEM05 for Patients With Multiple Myeloma Under 65 Years [Recruiting]
Interscalene Nerve Blocks With Ropivacaine Alone, With Dexamethasone, Plus Systemic Dexamethasone [Recruiting]
Phase II Study of Velcade, Decadron, and Doxil Followed by Cyclophosphamide in Multiple Myeloma [Recruiting]
A Study to Evaluate Two Different Regimens of VELCADE in Combination With Dexamethasone, Thalidomide and Cyclophosphamide (VDT vs VDTC)in Newly Diagnosed Multiple Myeloma [Recruiting]
Nausea and Pain Prophylaxis During Thyroid Surgery [Recruiting]
An Investigational Drug, PD 0332991, Is Being Studied In Combination With Velcade And Dexamethasone In Patients With Multiple Myeloma. Patients Must Have Received Prior Treatment For Multiple Myeloma. [Recruiting]
Dexamethasone to Treat Acute Chest Syndrome in People With Sickle Cell Disease [Recruiting]
Diphenhydramine, Lorazepam, and Dexamethasone in Treating Nausea and Vomiting Caused By Chemotherapy in Young Patients With Newly Diagnosed Cancer [Recruiting]
Dexamethasone Treatment of Congenital Adrenal Hyperplasia [Recruiting]
Dexamethasone in Cryptococcal Meningitis [Completed]
CC-5013 With or Without Dexamethasone in Treating Patients With Primary Systemic Amyloidosis [Completed]
Phase II Study of Thalidomide, Clarithromycin, Lenalidomide, and Dexamethasone for Newly Diagnosed Multiple Myeloma [Recruiting]
Dexamethasone With or Without Lenalidomide in Treating Patients With Previously Untreated Stage I, Stage II, or Stage III Multiple Myeloma [No longer recruiting]
Dexamethasone Pain Flare Study [Recruiting]
Study of Combination Therapy With VELCADE, Doxil, and Dexamethasone (VDd) in Multiple Myeloma
Safety/Efficacy of Antibiotic Steroid Combination in Treatment of Blepharitis and/or Keratitis and/or Conjunctivitis [Recruiting]
Velcade, Doxil, and Dexamethasone (VDd) as First Line Therapy for Multiple Myeloma
Combination Study of Revlimid®, Velcade® Dexamethasone and Doxil® (RVDD)for Newly Diagnosed Multiple Myeloma [Recruiting]
Oral Dexamethasone for the Treatment of Cervical Radiculopathy [Terminated]
Single Injection of Dexamethasone for Acute Bronchiolitis in Young Children [Completed]
IFM 2005-01: Velcade/Dexamethasone Versus Vincristine/Adriamycin (Doxorubicin)/Dexamethasone (VAD) for the Treatment of Patients With Multiple Myeloma [Recruiting]
Lenalidomide and Dexamethasone With/Without Transplant in Patients With Multiple Myeloma [Recruiting]
Velcade Combined With High-Dose Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma [Terminated]
Dexamethasone With or Without Oblimersen in Treating Patients With Relapsed or Refractory Multiple Myeloma [No longer recruiting]
Rituximab and Dexamethasone in Treating Patients With B-Cell Non-Hodgkin's Lymphoma [Recruiting]
Calcitriol Plus Dexamethasone in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy [Active, not recruiting]
Lenalidomide, Cyclophosphamide, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma [Suspended]
Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Treating Patients With Primary Liver Cancer That Cannot Be Removed By Surgery [Completed]
Combination Antiemetic Regimen for Prevention of PONV in Breast Surgery Patients [Recruiting]
Arsenic Trioxide, Thalidomide, Dexamethasone, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma [Active, not recruiting]
The Effects of Hypercapnia, Supplemental Oxygen, and Dexamethasone on Surgical Wound Infection [Recruiting]
Bortezomib-Dexamethasone-Doxorubicin-Study [Recruiting]
Epoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer [Active, not recruiting]
Bevacizumab, Lenalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Stage II or Stage III Multiple Myeloma [Recruiting]
Dexamethasone to Treat Oral Lichen Planus [Completed]
Lenalidomide, Dexamethasone, and Clarithromycin in Treating Patients Who Have Undergone Stem Cell Transplant for Multiple Myeloma [Recruiting]
Bortezomib and Dexamethasone in Treating Patients With Multiple Myeloma That Has Relapsed or Has Not Responded to Treatment [Recruiting]
Thalidomide, Dexamethasone, and Clarithromycin in Treating Patients Who Have Undergone a Previous Autologous or Syngeneic Bone Marrow or Stem Cell Transplant for Multiple Myeloma [Recruiting]
Bortezomib, Cyclophosphamide, Dexamethasone, and Thalidomide in Treating Patients With Newly Diagnosed, Previously Untreated Multiple Myeloma [Recruiting]
Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Treating Patients With Multiple Myeloma [Withdrawn]
Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Treating Patients With Chronic Idiopathic Myelofibrosis or Myelodysplastic or Myeloproliferative Disorders [Recruiting]
|
